狐狸视频

In addition to establishing potency, the team鈥檚 tests on cells and, later, mice showed that even high doses of the compound caused no ill effects. Read More

Identifying and quantifying skin lesions often requires hours of tedious visual inspection by experts, making it difficult to study a lot of them at once. Eric Tkaczyk and Daniel Fabbri have found that training multiple non-experts to do basic evaluations can achieve comparable results.

A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial.

An international team involving Vanderbilt researchers has discovered that a new 鈥渃heckpoint鈥� protein on immune system cells is active in tumors, and that blocking it 鈥� in combination with other treatments 鈥� is a successful therapeutic approach in mouse models of cancer.

Frogs don鈥檛 like living near noisy highways any better than people do, but research from Vanderbilt suggests that frogs, like hardened city-dwellers, can learn to adapt to the constant din of rumbling trucks, rolling tires and honking horns.

Vanderbilt University Medical Center recently received a $3.9 million grant from the National Institutes of Health to improve outcomes for children with significant hearing loss by providing individualized, prescription-like programming for their cochlear implants.

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren鈥檛 as effective as they could be. Oncologists haven鈥檛 had the right tools to predict drug interactions, other than in costly clinical trials. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team… Read More

Middle Tennessee children with autism spectrum disorder are 2.5 times more likely than children without ASD to be reported to the Child Abuse Hotline by age 8.

Matthew Tyska and colleagues have found that an adhesion protein in the gut is necessary for proper intestinal functioning.

Danny Winder and colleagues have demonstrated how norepinephrine and a stress factor call CRF interact, which may lead to new treatments for stress-related disorders.

Lawrence Marnett and colleagues have demonstrated how two enzymes cooperate to maintain even levels of an important cellular signaling molecule.

Timothy Cover, john Loh and colleagues have identified how a certain type of mutation influences the risk of premalignant and malignant changes in the stomach.

Inhibiting COX-2 — an enzyme associated with inflammation — could provide a novel therapeutic approach for stress-related psychiatric disorders.

IBM Watson Health has announced plans to make a 10-year, $50 million investment in joint research collaborations with Vanderbilt University Medical Center and Brigham and Women鈥檚 Hospital to advance the science of artificial intelligence and its application to major public health issues.

Using sophisticated gene sequencing and computing techniques, Vanderbilt researchers have achieved a first-of-its-kind glimpse into how the body鈥檚 immune system gears up to fight off infection.

But long before female-specific medications are available, treatment centers could use the information in this study to educate women about their stronger mental connections to places and objects. Read More

The symposium featured research by students in Vanderbilt's Medical Scholars Program, a one-year, in-depth research experience available to Vanderbilt and Meharry Medical College students with the central goal of training leaders in academic medicine.

People with blood type B, a relatively rare blood type, can expect similar outcomes from kidney transplants from type A2 donors, which increases the number of available kidneys for these patients. However, it requires additional monitoring and medication that can raise costs for patients.

Craig Brooks and colleagues have identified a mechanism of kidney fibrosis progression, suggesting a potential new angle for treating chronic kidney disease.

Zhijun Yin and colleagues have found that breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others--which enables doctors to better predict which patients are at risk of stopping their treatment early.